ABEONA THERAPEUTICS INC - COM (ABEO)

CUSIP: 00289Y107

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM
Total 13F shares
32,419,497
Share change
-3,502,447
Total reported value
$50,901,641
Put/Call ratio
47%
Price per share
$1.57
Number of holders
69
Value change
-$1,664,634
Number of buys
41
Number of sells
28

Quarterly Holders Quick Answers

What is CUSIP 00289Y107?
CUSIP 00289Y107 identifies ABEO - ABEONA THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ABEONA THERAPEUTICS INC - COM (ABEO) as of Q4 2020

As of 31 Dec 2020, ABEONA THERAPEUTICS INC - COM (ABEO) was held by 69 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,419,497 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Inc., VANGUARD GROUP INC, CITADEL ADVISORS LLC, Knoll Capital Management, LP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, and NORTHERN TRUST CORP. This page lists 69 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.